GlassScriptPhysician profile
Paul F Lachiewicz
NPI 1033210539
$137,209.06
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $17K · 2021: $38K · 2022: $26K · 2023: $1,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,463 · Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,462.50 |
| Food and Beverage | $233.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $132,781.30 | 2019-2023 | Zynrelef |
| Innocoll Pharmaceuticals Limited | $2,600.00 | 2021 | |
| Kci USA, INC. | $972.86 | 2022 | |
| Total Joint Orthopedics, INC. | $187.05 | 2019 | |
| Next Science LLC | $173.31 | 2022-2023 | Surgx, Blastx, Xperience |
| Smith+Nephew, INC. | $148.54 | 2023 | Legion, Legion Revision |
| Zimmer Biomet Holdings, INC. | $134.89 | 2019-2020 | |
| Medtronic USA, INC. | $77.92 | 2019 | |
| Pacira Therapeutics, INC. | $50.00 | 2019 | |
| Tactile Systems Technology INC | $38.03 | 2019 | |
| Medacta USA, INC. | $18.03 | 2019 | |
| Becton, Dickinson and Company | $13.80 | 2019 | |
| Convatec INC. | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lachiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.